RX) is seen as a beneficiary of Britain's need for more power, with analysts at JP Morgan giving the electricity generator an ‘Overweight' rating. Resuming its coverage at Overweight, with a target price of 1,000p, implying 46% upside potential, JP Morgan also previewed upcoming interim results (due 31 July) and tipped Drax to extend rewards for shareholders. 